Viyash Scientific Limited
Viyash Scientific Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: VIYASH and BSE: 512529 (ISIN INE807F01027).
It has a market capitalisation of ₹9,659 crore, a last close of ₹221.11 on 2026-10-19, a one-year return of 9.3%.
Valuation: a price-to-earnings ratio of 56.43x, a price-to-book ratio of 3.32x, a dividend yield of 0.0%.
Profitability: return on equity of 9.8%, return on capital employed of 17.5%, an operating margin of 18.9%.
Growth: sales growth of 34.0% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.15x, promoter holding of 49.2%.
| Metric | Value |
|---|---|
| Market capitalisation | 9,659 |
| Last close | ₹221.11 |
| P/E (TTM) | 56.43x |
| P/B | 3.32x |
| Dividend yield | 0.0% |
| ROE (FY) | 9.8% |
| ROCE (FY) | 17.5% |
| Operating margin (TTM) | 18.9% |
| Sales growth, 3-year CAGR | 34.0% |
| Debt / equity | 0.15x |
| Promoter holding | 49.2% |
| 1-year return | 9.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means